The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
Keyword(s):
2012 ◽
Vol 25
(1-2)
◽
1994 ◽
Vol 125
(2)
◽
pp. 189-195
◽
Keyword(s):
2004 ◽
Vol 3
(1)
◽
pp. 53-66
◽
Keyword(s):
2015 ◽
Vol 167
(11)
◽
pp. 2786-2794
◽
Keyword(s):
2001 ◽
Vol 233
(6)
◽
pp. 827-834
◽